Pubblicazioni

Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT

2021 - EUROPEAN JOURNAL OF HAEMATOLOGY

Garderet, L; Sbianchi, G; Iacobelli, S; Blaise, D; Byrne, Jl; Remenyi, P; Apperley, Jf; Touzeau, C; Isaksson, C; Browne, P; Mayer, J; Lenhoff, S; Muniz, Sg; Porras, Rp; Basak, G; Poire, X; Trneny, M; Nagler, A; Michieli, M; Tanase, A; Koster, L; Hayden, Pj; Beksac, M; Schonland, S; Yakoub-Agha, I

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric